| payload |
{"created_at":"2026-04-12T20:02:46.984 {"created_at":"2026-04-12T20:02:46.984964+00:00","signal_type":"market_headline_delta","source":"market_ingestor","url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxQSnBzcVhzYVdfOXU2Yzk4dnVjemlNd1RYUXozU29KeXF3bWEyLVNTTGZFTXk1UGkxQ0pCMV9HWE9Zd1BQR2RmcUU3cFRQU3ZFQk5pQlB2b0RyUzYtcGE3MjNVUWp3WDh6RzVPai1aWXZmbWRqMnFqWGxEaTBtdWxWdzlBVEZOd3YxXzBfU0Q3ME91dmRqWnRnUUF5RGZBdldsRER5by1kY0dqb0ZUVFFhRFdSTlBaRm9jd0lmSmN3?oc=5","value":{"fp":"4ec29576511d79ac","published_at":"2026-04-12T19:16:13+00:00","source":"AD HOC NEWS","source_domain":"ad-hoc-news.de","source_url":"https://www.ad-hoc-news.de","summary":"","tickers":[],"title":"Green Cross Corp (GC Biopharma) stock (KR7006280002): Is its plasma therapy focus strong enough for - AD HOC NEWS","url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxQSnBzcVhzYVdfOXU2Yzk4dnVjemlNd1RYUXozU29KeXF3bWEyLVNTTGZFTXk1UGkxQ0pCMV9HWE9Zd1BQR2RmcUU3cFRQU3ZFQk5pQlB2b0RyUzYtcGE3MjNVUWp3WDh6RzVPai1aWXZmbWRqMnFqWGxEaTBtdWxWdzlBVEZOd3YxXzBfU0Q3ME91dmRqWnRnUUF5RGZBdldsRER5by1kY0dqb0ZUVFFhRFdSTlBaRm9jd0lmSmN3?oc=5"}}... |